Misoprostol, a synthetic prostaglandin E1analogue, is an effective anti-ulcer drug as well as prescription drug for abortion induction. It is also illegally used for unsupervised self-induction of pregnancy termination. However failed abortion, leads to embryo exposure to the drug and is reported to result in congenital anomalies.The current study reports preliminary results of a pilot project designed for evaluating the effects of misoprostol administration on developing chick embryos. The project comprised of two groups of fertilized chicken eggs. The groups were labelled as "A" for control (n=5) and "B" for treated (n = 5) specimens. The treated group embryos were exposed to 4 µg of misoprostol by injecting the drug directly into the yolk sac, while same volume of normal saline was injected in the control group. Whole mount examination of sacrificed embryos after 33 hours of incubation revealed normal stage of development (HH-stage 10) in the control group embryos. While in the treated group, 02 out of 05 embryos lagged in their developmental stage (HH-stage 8), with no brain vesicles formation and lesser number of somite pairs.It is concluded that exposure of developing chick embryos to Misoprostol in a corresponding therapeutic dose of adult females can potentially cause developmental delay and growth regression of the embryos.